
Rechvog 0.3mg Tablet
Marketer
Rech Elist Pharma
Salt Composition
Voglibose (0.3mg)
Overview Rechvog 0.3mg Tablet
Diabetac 0.3mg tablets are prescribed for managing type 2 diabetes. This medication aids in post-meal blood glucose regulation, employed when diet and other similar treatments prove insufficient to control elevated blood sugar. Diabetac 0.3mg tablets should be ingested immediately prior to meals; dosage and frequency are determined individually by your physician for optimal blood sugar control. Discontinuation should only occur under medical supervision, as abrupt cessation may elevate blood sugar levels, potentially causing severe complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is crucial during treatment. Commonly reported side effects include gas, abdominal discomfort, appetite changes, constipation, and diarrhea. Report persistent or bothersome side effects to your physician. While Diabetac 0.3mg tablets themselves don't induce hypoglycemia, concurrent use with other diabetes medications (particularly insulin or sulfonylureas) may increase this risk, requiring treatment with plain glucose (not sucrose or common table sugar). Inform your doctor of any existing kidney or liver conditions before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should seek medical advice before use. Always disclose all other medications to your doctor to ensure safe usage. Excessive alcohol consumption should be avoided due to a potential increased risk of hypoglycemia.
Uses of Rechvog 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Rechvog 0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Rechvog 0.3mg Tablet on an empty stomach.
Common Side effects of Rechvog 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Rechvog 0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Rechvog 0.3mg Tablet on an empty stomach.
How Rechvog 0.3mg Tablet works:
Glucodown 0.3mg tablets are used to manage diabetes. These tablets work by blocking the enzymes in the gut that digest complex carbohydrates into simple sugars like glucose, thus moderating post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption while taking Rechvog 0.3mg tablets is contraindicated.
PregnancySAFE IF PRESCRIBED
The use of Rechvog 0.3mg Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, clinical data in humans are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Rechvog 0.3mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Rechvog 0.3mg Tablet.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Rechvog 0.3mg tablets. Dosage modification of Rechvog 0.3mg tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Rechvog 0.3mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Rechvog 0.3mg Tablet :
Omit any missed dose of Rechvog 0.3mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rechvog 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
